August 21, 2019 posted by

Primera página del artículo de sobre bronquiectasias. THEODORE WILLIAMS, C. la fisiopatología de las bronquiectasias. El conocimiento acerca de. RESUMO: As bronquiectasias, outrora frequentes, têm vindo a tomarse numa situação patológia comparativamente rara. No entanto, a sua importância clínica . Las bronquiectasias no asociadas a fibrosis quística son una enfermedad compleja que ha despertado cada vez más interés científico debido a su creciente.

Author: JoJor JoJojar
Country: Ecuador
Language: English (Spanish)
Genre: Relationship
Published (Last): 24 March 2013
Pages: 395
PDF File Size: 4.17 Mb
ePub File Size: 18.18 Mb
ISBN: 281-7-90130-893-9
Downloads: 58909
Price: Free* [*Free Regsitration Required]
Uploader: Vuran

Mortality in non-cystic fibrosis bronchiectasis: A prospective cohort analysis.

There was a problem providing the content you requested

Ann Am Thorac Soc. Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis.

Se airway bacterial communities in adult bronchiectasis patients. State of the art review: Controlled trial of ceftazidime vs. Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis.

Bronquiectasias | Blausen Medical

Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: Systemic comorbidities in bronchiectasis. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.


Bronchiectasis-associated hospitalizations in Germany, Microbiologic follow-up ee in adult bronchiectasis. A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Socioeconomic deprivation, readmissions, mortality and acute exacerbations of bronchiectasis.

Chest physiotherapy techniques in bronchiectasis. Assessing response to treatment of exacerbations of bronchiectasis in adults.

Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Exacerbations in cystic fibrosis: The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis–a randomised controlled trial.

British Thoracic Society guideline for non-CF bronchiectasis. Prevalence and factors associated with isolation of D and Candida from sputum in patients with noncystic fibrosis bronchiectasis. Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis. Ceftazidime compared with gentamicin and carbenicillin in patients with cystic fibrosis, pulmonary pseudomonas infection, and an exacerbation of respiratory symptoms.

Kellett F, Robert NM. Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasis. Inhaled hyperosmolar agents for bronchiectasis.

A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis. Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: Recent Advances and Continuing Challenges. Cochrane Database Syst Rev.


Symptoms of airway reflux predict exacerbations and quality of life in bronchiectasis. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.

Servicio de ayuda de la revista. Goyal V, Chang AB. The bronchiectasis severity index. Multidimensional approach to non-cystic fibrosis bronchiectasis: Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Clinical measures of bronquiectaslas in adult non-CF bronchiectasis correlate with airway microbiota composition.

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: Inhaled steroids for bronchiectasis.